Kabzaa box office collection day 9: Kichcha Sudeep’s film struggles at theatres

By Prachi Arya:

The recent release Kabzaa, starring Kichcha Sudeep, Shriya Saran and Upendra in significant roles, has been struggling to get numbers at the box office. The movie that was mounted on a huge scale has fallen short of expectations. Despite being released in multiple languages and heavily promoted, the film has failed to get footfalls in theatres.

KABZAA BO COLLECTION

On its ninth day, the film roughly earned 1.75 crore across all languages, as per early estimates. The total for the stands at Rs 32.78 crore, which is far below the film’s production budget of Rs 120 crore. This indicates that the movie is unlikely to make any profit. Given the film’s poor performance at the box office, it seems likely that it will end up being a huge financial loss for its makers. Not just the production budget, however, the poor performance at the domestic ticket counters will also affect its production costs.

ABOUT KABZAA

For those unaware, Kabzaa is a period action film written and directed by R Chandru. The film stars Upendra, Kichcha Sudeep and Shriya Saran in lead roles along with Shiva Rajkumar in a cameo role, which gave a lead to the second part of the film. Reportedly, the film was made on a budget of Rs 120 crore.

Murali Sharma, Nawab Shah, Kota Srinivasa Rao, John Kokken, Dev Gill, Kabir Duhan Singh and Suneel Puranik are part of the supporting cast. Cinematographer AJ Shetty, editor Mahesh S Reddy and composer Ravi Basrur form the technical crew.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
These Flood Safety Tips Can Help You Prepare for an Emergency thumbnail

These Flood Safety Tips Can Help You Prepare for an Emergency

If you’ve tuned into the news lately, you’ve likely seen at least some coverage of the floods that are impacting various parts of the world. Over the summer, the devastating floods in Pakistan—which have killed more than 1,500 people in the area, including more than 500 children—have highlighted just how dangerous this type of natural
Read More
Vegan Diet Helps Shed Pounds but Doesn't Dint Diabetes thumbnail

Vegan Diet Helps Shed Pounds but Doesn’t Dint Diabetes

Following a vegan diet for at least 3 months helped people with overweight or type 2 diabetes shed the pounds, but only had a marginal effect on HbA1c levels, on average, new research indicates. No effect was seen on blood pressure, triglycerides, or the "good" high-density lipoprotein (HDL) cholesterol. HbA1c was reduced by a mean of…
Read More
Acetazolamide May Help COPD Patients Reach New Heights thumbnail

Acetazolamide May Help COPD Patients Reach New Heights

Meeting Coverage > ERS — Along with self-monitoring, treatment limited altitude-related adverse health effects vs placebo by Elizabeth Short, Staff Writer, MedPage Today September 13, 2023 Acetazolamide may prevent some patients with chronic obstructive pulmonary disease (COPD) from suffering altitude-related adverse health effects (ARAHE) when traveling, a randomized controlled trial showed. In patients with moderate
Read More
Yescarta Label Updated: Prophylactic Steroids to Prevent CRS thumbnail

Yescarta Label Updated: Prophylactic Steroids to Prevent CRS

The label for axicabtagene ciloleucel (Yescarta, Kite) has been updated to include prophylactic corticosteroids to manage cytokine release syndrome (CRS). This is a chimeric antigen receptor T-cell product indicated for use in adult patients with relapsed or refractory large B-cell lymphoma (LBCL) after two or more lines of systemic therapy. The product label carries a…
Read More
Index Of News
Total
0
Share